Efficacy And Safety Of Glycopyrronium In COPD Patients With Moderate-To-Severe Airflow Limitation: The Gem1 Study

被引：0
|
作者：
LaForce, C. [1 ]
Pearle, J. [2 ]
Feldman, G. [3 ]
Spangenthal, S. [4 ]
Eckert, J. H. [5 ]
Mota, F. [5 ]
Henley, M. [6 ]
D'Andrea, P. [6 ]
机构：
[1] North Carolina Clin Res, Raleigh, NC USA
[2] Calif Res Med Grp Inc, Fullerton, CA USA
[3] S Carolina Pharmaceut Res, Spartanburg, SC USA
[4] Amer Hlth Res Charlotte, Charlotte, NC USA
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Pharmaceut, E Hanover, NJ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5745
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study
    LaForce, Craig
    Feldman, Gregory
    Spangenthal, Selwyn
    Eckert, Joerg H.
    Henley, Michelle
    Patalano, Francesco
    D'Andrea, Peter
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 1233 - 1243
  • [2] Safety Profile of Glycopyrronium Compared With Once-Daily Indacaterol in Patients With COPD With Moderate-to-Severe Airflow Limitation: The GEM3 Study
    Mahler, Donald
    Gifford, Alex
    Satti, Aditi
    Jessop, Nicola
    Eckert, Joerg H.
    D'Andrea, Peter
    Banerjee, Rudrani
    CHEST, 2015, 148 (04)
  • [3] Cardiovascular Safety of Glycopyrronium in Patients With Moderate-to-Severe COPD: Pooled Analysis From the GEM1, GEM2, FLIGHT1, and FLIGHT2 Studies
    Kerwin, Edward
    Laforce, Craig
    Pedinoff, Andrew
    Di Giovanni, Robert
    Jessop, Nicola
    Henley, Michelle
    D'Andrea, Peter
    CHEST, 2015, 148 (04)
  • [4] Glycopyrronium Demonstrates Significant Improvements in Lung Function in Patients With Moderate-to-Severe COPD: Pooled Analysis From the GEM1 and GEM2 Studies
    Kerwin, Edward
    Spangenthal, Selwyn
    Miller, S. David
    D'Andrea, Peter
    Henley, Michelle
    Eckert, Joerg H.
    Patalano, Francesco
    CHEST, 2015, 148 (04)
  • [5] Glycopyrronium Twice Daily Improves Lung Function And Health Status And Is Well Tolerated In COPD Patients With Moderate-To-Severe Airflow Limitation: The Gem2 Study
    Kerwin, E. M.
    Siler, T. M.
    Korenblat, P. E.
    White, A. C.
    Eckert, J. H.
    Cha, E.
    Mota, F.
    Andrea, P. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [6] EFFICACY AND SAFETY OF INDACATEROL IN PATIENTS WITH DESTROYED LUNG BY TUBERCULOSIS AND MODERATE-TO-SEVERE AIRFLOW LIMITATION: THE INFINITY STUDY
    Yoo, Chul-Gyu
    Kim, Cheong-Ju
    Yoon, Hyoung-Kyu
    Park, Myung-Jae
    Yoo, Kwang-Ha
    Jung, Ki-Suck
    Park, Jeong-Woong
    Lim, Seong Yong
    Shim, Jae Jeong
    Lee, Yong Chul
    Kim, Young-Sam
    Oh, Yeon-Mok
    Kim, Song
    RESPIROLOGY, 2015, 20 : 39 - 39
  • [7] Glycopyrronium Improved Health Status, Dyspnea, and Reduced Rescue Medication Use in Patients With Moderate-to-Severe COPD: Pooled Analysis From GEM1 and GEM2 Studies
    Laforce, Craig
    Kerwin, Edward
    Spangenthal, Selwyn
    D'Andrea, Peter
    Henley, Michelle
    Eckert, Joerg H.
    Patalano, Francesco
    CHEST, 2015, 148 (04)
  • [8] Efficacy Of Inhaled Glycopyrrolate For Moderate-To-Severe COPD: A Subgroup Analysis By Gender From The Pooled Gem1 And Gem2 Studies
    Mahler, D. A.
    Satti, A.
    Spangenthal, S.
    Yadao, A.
    D'Andrea, P.
    Uddin, A.
    Franke-Bray, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [9] Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to-severe COPD
    Salvi, Sundeep
    Jain, Manish K.
    Krishnamurthy, Srikanth
    Balki, Akash
    Kodgule, Rahul
    Tandon, Monika
    Bhagat, Sagar
    Panchal, Sagar
    Khatri, Nishtha
    Wu, Wen
    Pendse, Amol
    Patil, Saiprasad
    Barkate, Hanmant
    LUNG INDIA, 2022, 39 (06) : 517 - 524
  • [10] Glycopyrronium Is Safe And Well Tolerated In Patients With Moderate-To-Severe COPD
    Kerwin, E. M.
    D'Urzo, A. D.
    Overend, T.
    Goyal, P.
    Chen, H.
    Banerji, D.
    McBryan, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
12345